Irans Defiance and Stalled Diplomacy Heighten Geopolitical Risks in the Middle East Thousands of Stock Trades Tied to Trump Under BBC Spotlight Estate Dispute Raises Concerns Over Transparency in Family Inheritance Management Waymo Expands Robotaxi Fleet with Ojai Vehicles Opens Access to Select Riders Amid CostCutting Push Bitcoin Volatility Hits NineMonth Low Crypto Markets Enter Boring Phase as Institutional Adoption Deepens Walmart Kroger and ELF Beauty Announce Price Cuts Potential Margin Pressures Ahead CANF Q4 2023 Earnings EPS Surges Past Estimates as Clinical Progress Continues JLL Q1 2026 Earnings Solid EPS Beat Amid Cautious Market Sentiment XTKG Q4 2019 Earnings Significant EPS Miss and Steep Stock Decline Kaltura Q1 2026 Earnings EPS Surges Past Estimates as Profitability Improves enCore Energy Q1 2026 Earnings Surprise Profit Beats Estimates Stock Rises CXW Q1 2026 Earnings CoreCivic Reports EPS Beat Stock Rises VCI Global VCIG Skyrockets 6479 Surge Tests Key Resistance at 140 Solaris Resources Holds Steady Near Support After Minor Decline KB Financial Group KB Faces Selling Pressure as Shares Dip 137 Super Micro Computer SMCI Edges Lower as Consolidation Holds Above Key Support JELDWEN Holding Inc JELD Stages a Modest Recovery Navigating Support and Resistance Levels AI Memory Bottleneck Drives Roundhill Memory ETF to Record 10 Billion in Assets VLRS Q1 2026 Earnings NarrowerthanExpected Loss Delivers Positive Surprise Amid Operational Headwinds Telomir Pharmaceuticals TELO Consolidates Near 129 as Support and Resistance Levels Tighten INSM Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction IOR Q4 2024 Earnings Positive Earnings Amid Limited Market Visibility Saga Q1 2026 Earnings Negative EPS and Stock Decline Amidst Industry Headwinds Verisk Analytics Q1 2026 Earnings EPS Beat Fuels Solid Start to Fiscal Year Bragg Gaming Group BRAG Q1 2026 Earnings NarrowerThanExpected Loss Despite Stock Dip NanoViricides Inc NNVC Q1 2026 Earnings Narrower Loss Drives Positive Stock Reaction RNTX Q1 2026 Earnings EPS Beats Estimates as Preclinical Stage Biotech Tightens Spending